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Background -A study was undertaken to compare the efficacy of short term tube thoracostomy drainage with standard tube thoracostomy drainage before instillation of tetracycline for sclerotherapy of malignant pleural effusions. Methods -The study consisted of a randomised clinical trial in a sequential sample of 25 patients with malignant pleural effusions documented cytopathologically. Fifteen patients were randomly assigned to group 1 (standard protocol) and 10 to group 2 (short term protocol). Patients in group 1 had tube thoracostomy suction drainage until radiological evidence of lung re-expansion was obtained and the amount of fluid drained was < 150 ml/day, before tetracycline (1P5 g) was instilled. The chest tube was removed when the amount of fluid drained after instillation was < 150 ml/day. Patients in group 2 also had suction drainage, but the tetracycline (15 g ) was instilled when the chest radiograph showed the lung to be re-expanded and the effusion drained, which was usually within 24 hours. The chest tube was removed the next day. Results -The response to tetracycline sclerotherapy in the two groups was the same (80%) but the duration of chest tube drainage was significantly shorter for patients in group 2 (median two days) than for those in group 1 (median seven days). Conclusions -The duration of chest tube drainage before sclerotherapy for malignant pleural effusions need not be influenced by the amount of fluid drained daily but by radiographic evidence of fluid evacuation and lung re-expansion. Shorter duration of drainage will reduce the length of hospital stay without sacrificing the efficacy of pleurodesis. groups. Patients in group 1 (standard protocol described by Sahn34) underwent tube thoracostomy suction drainage until re-expansion of the lung and until the amount of fluid drained was less than 150 ml/day. Tetracycline (1-5 g diluted in 100-150 ml normal saline solution plus 20 ml 1% lignocaine) was then instilled intrapleurally. The chest tube was removed when the amount of fluid drained after instillation was less than 150 ml/day. Patients in group 2 (short term protocol) also had tube thoracostomy suction drainage, but the tetracycline (1 5 g diluted in the same manner) was instilled as soon as full re-expansion of the lung was radiologically documented, which was usually within 24 hours. The chest tube was removed the day after instillation of tetracycline. Other aspects of the pleurodesis technique were similar in the two groups. For pleural drainage a 28-French intercostal drainage catheter was inserted by the standard technique. After instillation of the tetracycline the tube was clamped and the position of the patient was rotated by the method described by Wallach.438 The tube was unclamped and suction drainage was resumed until the chest tube was removed. A follow up chest radiograph was obtained after 30 days to determine the response to sclerotherapy. Subsequent follow up was provided by the patient's primary care physician.
STATISTICAL ANALYSIS
The two groups were compared with respect to demographic characteristics, site of primary tumour, duration of chest tube drainage, response to sclerotherapy, length of follow up study, and patient outcome. The response to sclerotherapy was determined by criteria described by Hausheer and Yarbo.35 A response was defined as having no fluid reaccumulation for at least one month as determined by chest 
Results
Between May 1989 and August 1991 25 patients entered the study. Fifteen were randomly assigned to group 1 (standard protocol) and 10 to group 2 (short term protocol). The asymmetry between the size of the two groups was a result of the randomisation process. The demographic and primary disease characteristics are summarised in table 1. No significant difference existed between the two groups with regard to age or sex distribution. The frequency of carcinoma of the breast or lung, the most common primary tumour sites, was similar for both groups.
The data on duration of chest tube drainage, response to sclerotherapy, length of follow up study, and patient outcome are summarised in table 2. As expected, the duration of chest tube drainage was significantly shorter for patients in group 2 (median two days) than for those in group 1 (median seven days). Two patients in group 2 required a relatively long period of drainage; one had slow re-expansion of the lung because of partial airway obstruction by tumour, and one had a prolonged bronchopleural fistula as a result of carcinoma of the lung.
The response to sclerotherapy was similar in the two groups, both having about an 80% response rate. The two patients in group 2 whose treatment failed had subsequent tube thoracostomy drainage and instillation of tetracycline by the standard protocol. Repeated attempts at sclerotherapy failed in both patients. With the use of tetracycline as the sclerosing agent, no difference in efficacy was found whether we waited until the daily chest tube drainage was less than 150 ml/day, as recommended by some authors,'6 3436 or whether tetracycline was instilled as soon as the chest radiograph showed lung re-expansion which was usually within 24 hours. Both groups had an 80% response rate to tetracycline sclerotherapy, similar to published results.?6 The duration of chest tube drainage, however, differed greatly. The median duration for patients in group 1 (seven days) was significantly longer than that for patients in group 2 (two days).
Two studies have been reported in which the authors stated that the duration of pleural drainage before instillation of the sclerosing agent was less than 24 hours; both reported successful pleurodesis.64' One study'5 used intrapleural suction "until roentgenograms confirmed complete evacuation of the pleural space and complete lung expansion" before successful tetracycline pleurodesis, but did not report the duration of drainage. McAlpine et a149 surveyed chest physicians in the United Kingdom and found that "those using intercostal tube drainage tended to remove the drain either immediately or within 24 hours". They found that only 13% of respiratory physicians and 23% of thoracic surgeons varied the duration of drainage according to the volume of fluid drained-each day. Our study is the first to show in a prospective randomised trial that short term drainage before sclerotherapy is, indeed, effective.
We feel that, regardless of the sclerosing agent used, the duration of chest tube drainage need not be guided by the amount of fluid drained but by radiological evidence of fluid evacuation and lung re-expansion. This can result in a shorter duration of drainage, thus reducing the number of days in hospital and improving patient comfort without sacrificing efficacy of pleurodesis.
